SG10202101830WA - Processes for preparing oligomers - Google Patents
Processes for preparing oligomersInfo
- Publication number
- SG10202101830WA SG10202101830WA SG10202101830WA SG10202101830WA SG10202101830WA SG 10202101830W A SG10202101830W A SG 10202101830WA SG 10202101830W A SG10202101830W A SG 10202101830WA SG 10202101830W A SG10202101830W A SG 10202101830WA SG 10202101830W A SG10202101830W A SG 10202101830WA
- Authority
- SG
- Singapore
- Prior art keywords
- processes
- preparing oligomers
- oligomers
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662341049P | 2016-05-24 | 2016-05-24 | |
| US201662357072P | 2016-06-30 | 2016-06-30 | |
| US201662357166P | 2016-06-30 | 2016-06-30 | |
| US201662356923P | 2016-06-30 | 2016-06-30 | |
| US201662357153P | 2016-06-30 | 2016-06-30 | |
| US201762508256P | 2017-05-18 | 2017-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202101830WA true SG10202101830WA (en) | 2021-04-29 |
Family
ID=59078165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202101830WA SG10202101830WA (en) | 2016-05-24 | 2017-05-24 | Processes for preparing oligomers |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10875880B2 (en) |
| EP (2) | EP3564248A1 (en) |
| JP (2) | JP7008642B2 (en) |
| KR (1) | KR102506298B1 (en) |
| CN (1) | CN109563114B (en) |
| AU (1) | AU2017269355B2 (en) |
| BR (2) | BR112018074346B1 (en) |
| CA (1) | CA3025339A1 (en) |
| CO (1) | CO2018013838A2 (en) |
| DK (1) | DK3464305T3 (en) |
| ES (1) | ES2993738T3 (en) |
| FI (1) | FI3464305T3 (en) |
| HR (1) | HRP20241428T1 (en) |
| IL (1) | IL263149B2 (en) |
| MA (2) | MA45154B1 (en) |
| MD (1) | MD3464305T2 (en) |
| MX (2) | MX384727B (en) |
| SA (1) | SA518400500B1 (en) |
| SG (1) | SG10202101830WA (en) |
| TW (2) | TWI738784B (en) |
| WO (1) | WO2017205496A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541024B (en) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | Antisense nucleic acid |
| AU2017270598B2 (en) * | 2016-05-24 | 2022-12-01 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| SG10202101836TA (en) | 2016-05-24 | 2021-03-30 | Sarepta Therapeutics Inc | Processes for preparing phosphorodiamidate morpholino oligomers |
| MA45362A (en) * | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | PROCESSES FOR THE PREPARATION OF MORPHOLINO OLIGOMERS OF PHOSPHORODIAMIDATE |
| PT3464306T (en) * | 2016-05-24 | 2024-05-17 | Sarepta Therapeutics Inc | Processes for preparing phosphorodiamidate morpholino oligomers |
| HRP20241428T1 (en) | 2016-05-24 | 2025-01-03 | Sarepta Therapeutics, Inc. | PROCEDURES FOR PREPARATION OF OLIGOMERS |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| CN109152775B (en) * | 2016-06-30 | 2022-04-26 | 萨勒普塔医疗公司 | Process for preparing phosphoric acid diamide morpholino oligomer |
| ES2963336T3 (en) * | 2017-09-25 | 2024-03-26 | Sarepta Therapeutics Inc | Processes for preparing morpholino phosphorodiamidate oligomers by rapid flow synthesis |
| JP2021521794A (en) * | 2018-04-26 | 2021-08-30 | サレプタ セラピューティクス， インコーポレイテッド | Exon skipping oligomers and oligomeric conjugates for muscular dystrophy |
| EP4658280A2 (en) * | 2023-02-01 | 2025-12-10 | Alnylam Pharmaceuticals, Inc. | Six membered ring containing oligomers |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3687030T2 (en) | 1985-03-15 | 1993-03-11 | Eugene Stirchak | STEREO-REGULAR POLYNUCLEOTID-BINDING POLYMERS. |
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| US5166315A (en) | 1989-12-20 | 1992-11-24 | Anti-Gene Development Group | Sequence-specific binding polymers for duplex nucleic acids |
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| AU4225889A (en) | 1988-09-01 | 1990-04-02 | Forskningscenter Riso | Peptide synthesis method and solid support for use in the method |
| WO1995018128A1 (en) | 1993-12-29 | 1995-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine adenosine antagonists |
| US7572582B2 (en) | 1997-09-12 | 2009-08-11 | Exiqon A/S | Oligonucleotide analogues |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| US7084125B2 (en) | 1999-03-18 | 2006-08-01 | Exiqon A/S | Xylo-LNA analogues |
| JP2002543214A (en) | 1999-05-04 | 2002-12-17 | エクシコン エ／エス | L-ribo-LNA analog |
| KR20020097241A (en) | 2000-05-04 | 2002-12-31 | 에이브이아이 바이오파마 인코포레이티드 | Splice-region antisense composition and method |
| CA2459347C (en) | 2001-09-04 | 2012-10-09 | Exiqon A/S | Locked nucleic acid (lna) compositions and uses thereof |
| US7569575B2 (en) | 2002-05-08 | 2009-08-04 | Santaris Pharma A/S | Synthesis of locked nucleic acid derivatives |
| WO2004043977A2 (en) | 2002-11-05 | 2004-05-27 | Isis Pharmaceuticals, Inc. | 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| US7759513B2 (en) | 2003-02-21 | 2010-07-20 | Nigu Chemie Gmbh | Photolabile protective groups for improved processes to prepare oligonucleotide arrays |
| SI1766010T1 (en) | 2004-06-28 | 2011-06-30 | Univ Western Australia | Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| EP2735568B8 (en) * | 2006-05-10 | 2017-09-27 | Sarepta Therapeutics, Inc. | Oligonucleotide analogs having cationic intersubunit linkages |
| US9371348B2 (en) | 2006-11-27 | 2016-06-21 | The Trustees Of The University Of Pennsylvania | Photocleavable oligonucleotide and uses thereof |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| HRP20140646T1 (en) * | 2007-11-15 | 2014-09-26 | Sarepta Therapeutics, Inc. | Method of synthesis of morpholino oligomers |
| CA3066050A1 (en) | 2008-10-24 | 2010-04-29 | Sarepta Therapeutics, Inc. | Multiple exon skipping compositions for dmd |
| US20120149756A1 (en) | 2009-04-10 | 2012-06-14 | Associatin Institut de Myologie | Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease |
| WO2011057350A1 (en) | 2009-11-12 | 2011-05-19 | The University Of Western Australia | Antisense molecules and methods for treating pathologies |
| TWI463423B (en) * | 2010-05-28 | 2014-12-01 | Poynt Corp | Method of using location information for advertising system based on 3-dimensional shapes |
| TWI620756B (en) * | 2010-05-28 | 2018-04-11 | 薩羅塔治療公司 | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups |
| TWI541024B (en) * | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | Antisense nucleic acid |
| KR101764462B1 (en) | 2010-09-30 | 2017-08-02 | 니뽄 신야쿠 가부시키가이샤 | Morpholino nucleic acid derivative |
| MX2013009191A (en) * | 2011-02-08 | 2013-11-04 | Charlotte Mecklenburg Hospital | Antisense oligonucleotides. |
| SG11201400135SA (en) | 2011-08-23 | 2014-03-28 | Univ Mcgill | Ionic tags for synthesis of oligoribonucleotides |
| PL2581448T3 (en) | 2011-10-13 | 2015-08-31 | Association Inst De Myologie | Tricyclo-phosphorothioate DNA |
| EA202090338A1 (en) | 2011-11-18 | 2021-04-30 | Сарепта Терапьютикс, Инк. | Functionally Modified Oligonucleotides and Their Subunits |
| CA2857664A1 (en) * | 2011-11-30 | 2013-06-06 | Sarepta Therapeutics, Inc. | Antisense oligonucleotides targeting within the smn2 pre-mrna for use ininduced exon inclusion in spinal muscle atrophy |
| CN117721110A (en) * | 2011-12-28 | 2024-03-19 | 日本新药株式会社 | antisense nucleic acid |
| EP2820155B1 (en) | 2012-02-28 | 2017-07-26 | Population Genetics Technologies Ltd. | Method for attaching a counter sequence to a nucleic acid sample |
| CN102702265A (en) * | 2012-05-14 | 2012-10-03 | 天津特安化学科技有限公司 | Phosphorodiamidate morpholino oligomer synthetized by solid phase and method thereof |
| MX366485B (en) * | 2013-03-14 | 2019-07-10 | Sarepta Therapeutics Inc | COMPOSITIONS FOR EXON JUMPING FOR THE TREATMENT OF MUSCULAR DYSTROPHY. |
| EP3495485A3 (en) * | 2013-03-14 | 2019-08-21 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| US20140329762A1 (en) | 2013-03-15 | 2014-11-06 | Sarepta Therapeutics, Inc. | Compositions for treating muscular dystrophy |
| EP3015467B1 (en) | 2013-05-24 | 2024-12-04 | Ajinomoto Co., Inc. | Morpholino oligonucleotide manufacturing method |
| SG10202101836TA (en) | 2016-05-24 | 2021-03-30 | Sarepta Therapeutics Inc | Processes for preparing phosphorodiamidate morpholino oligomers |
| HRP20241428T1 (en) | 2016-05-24 | 2025-01-03 | Sarepta Therapeutics, Inc. | PROCEDURES FOR PREPARATION OF OLIGOMERS |
| PT3464306T (en) * | 2016-05-24 | 2024-05-17 | Sarepta Therapeutics Inc | Processes for preparing phosphorodiamidate morpholino oligomers |
| MA45362A (en) | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | PROCESSES FOR THE PREPARATION OF MORPHOLINO OLIGOMERS OF PHOSPHORODIAMIDATE |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| PL3554554T3 (en) | 2016-12-19 | 2022-12-19 | Sarepta Therapeutics, Inc. | Exon-skipping oligomer conjugates in muscular dystrophy |
| DK3554552T3 (en) | 2016-12-19 | 2022-10-24 | Sarepta Therapeutics Inc | EXON SKIPPING OLIGOMER CONJUGATES AGAINST MUSCULAR DYSTROPHY |
| LT3554553T (en) | 2016-12-19 | 2022-08-25 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
| EA201991450A1 (en) | 2017-09-22 | 2019-12-30 | Сарепта Терапьютикс, Инк. | OLIGOMER CONJUGATES FOR EXONISM SKIP IN MUSCULAR DYSTROPHY |
-
2017
- 2017-05-24 HR HRP20241428TT patent/HRP20241428T1/en unknown
- 2017-05-24 AU AU2017269355A patent/AU2017269355B2/en active Active
- 2017-05-24 JP JP2018562078A patent/JP7008642B2/en active Active
- 2017-05-24 MD MDE20190423T patent/MD3464305T2/en unknown
- 2017-05-24 MA MA45154A patent/MA45154B1/en unknown
- 2017-05-24 MX MX2018014472A patent/MX384727B/en unknown
- 2017-05-24 CA CA3025339A patent/CA3025339A1/en active Pending
- 2017-05-24 EP EP19174995.1A patent/EP3564248A1/en active Pending
- 2017-05-24 WO PCT/US2017/034235 patent/WO2017205496A1/en not_active Ceased
- 2017-05-24 TW TW106117189A patent/TWI738784B/en active
- 2017-05-24 KR KR1020187036117A patent/KR102506298B1/en active Active
- 2017-05-24 DK DK17731336.8T patent/DK3464305T3/en active
- 2017-05-24 SG SG10202101830WA patent/SG10202101830WA/en unknown
- 2017-05-24 CN CN201780037531.XA patent/CN109563114B/en active Active
- 2017-05-24 TW TW110113938A patent/TWI801843B/en active
- 2017-05-24 US US16/303,356 patent/US10875880B2/en active Active
- 2017-05-24 ES ES17731336T patent/ES2993738T3/en active Active
- 2017-05-24 EP EP17731336.8A patent/EP3464305B1/en active Active
- 2017-05-24 BR BR112018074346-1A patent/BR112018074346B1/en active IP Right Grant
- 2017-05-24 FI FIEP17731336.8T patent/FI3464305T3/en active
- 2017-05-24 BR BR122022014984-7A patent/BR122022014984B1/en active IP Right Grant
- 2017-05-24 MX MX2021008539A patent/MX2021008539A/en unknown
- 2017-05-24 MA MA049775A patent/MA49775A/en unknown
-
2018
- 2018-11-20 IL IL263149A patent/IL263149B2/en unknown
- 2018-11-24 SA SA518400500A patent/SA518400500B1/en unknown
- 2018-12-19 CO CONC2018/0013838A patent/CO2018013838A2/en unknown
-
2020
- 2020-11-16 US US17/098,935 patent/US11384105B2/en active Active
-
2021
- 2021-07-15 JP JP2021117392A patent/JP2021176967A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263149A (en) | Processes for preparing oligomers | |
| IL248960A0 (en) | Processes for preparing antiviral compounds | |
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| IL274439A (en) | Process for preparing tapinarof | |
| IL252912B (en) | Processes for preparing oxathiazin-like compounds | |
| SI3371150T1 (en) | Process for preparing brivaracetam | |
| GB201807019D0 (en) | Locking apparatus | |
| ZA201706505B (en) | Processes for preparing fluoroketolides | |
| IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
| PL3160984T3 (en) | Process for preparing d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide | |
| ZA201903463B (en) | Method for preparing hexadecahydropyrene | |
| GB2554505B (en) | Locking Apparatus | |
| ZA201908452B (en) | Improved process for preparing imetelstat | |
| IL249283A0 (en) | Process for preparing 3-chloro-2-vinylphenol | |
| TWI560352B (en) | Locking apparatus | |
| HUE064118T2 (en) | Process for preparing ethene | |
| HK40005805B (en) | Processes for preparing oligomers | |
| ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
| GB2553087B (en) | Locking apparatus | |
| GB201703135D0 (en) | Locking apparatus |